An Open-Label Trial of Triheptanoin in Patients With Glucose Transporter Type-1 Deficiency Syndrome

NCT02036853 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Glucose Transporter Type-1 Deficiency Syndrome (Glut1 DS)

Interventions

DRUG: Triheptanoin

Sponsor

Adrian Lacy

Collaborators

[object Object]